{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T10:24:48Z","timestamp":1750328688168},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T00:00:00Z","timestamp":1685059200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Tumor necrosis factor exerts many adverse biological effects, from cell proliferation to cell death. Accurate diagnosis and treatment are therefore difficult due to many factors influencing tumor necrosis factor-alpha (TNF-\u03b1) signaling, including microRNAs (miRNAs), especially in tumors. The aim of the study was to determine the influence of miRNAs on the expression profile of genes and proteins related to TNF-\u03b1 signaling in endometrial cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The material consisted of 45 endometrioid endometrial cancer and 45 normal endometrium tissue samples. Gene expression was determined with microarrays and then validated for TNF-\u03b1, tumor necrosis factor receptor 1 (TNFR1) and 2 (TNFR2), caveolin 1 (CAV1), nuclear factor kappa B subunit 1 (NFKB1), and TGF-beta activated kinase 1 (MAP3K7)-binding protein 2 (TAB2) using real-time quantitative reverse transcription reaction (RT-qPCR). The protein concentration was assessed by enzyme-linked immunosorbent assay (ELISA). In addition, differentiating miRNAs were identified using miRNA microarrays and their relationships with TNF-\u03b1 signaling genes were evaluated using the mirDIP tool.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>TNF-\u03b1, TNFR1, TNFR2, CAV1, NFKB1, and TAB2 were upregulated both on the mRNA and protein levels. The decrease in the activity of miR-1207-5p, miR-1910-3p, and miR-940 may be related to CAV1 overexpression. Similarly for miR-572 and NFKB1 as well as miR-939-5p and TNF-\u03b1. In turn, miR-3178 may partially inhibit TNFR1 activity up to grade 2 cancer.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>TNF-\u03b1 signaling, especially the TNF-\u03b1\/NF-\u03baB axis, is disrupted in endometrial cancer and worsens with disease progression. The observed changes may be the result of miRNAs\u2019 activity in the initial stage of endometrial cancer and its gradual loss in later grades.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00432-023-04863-3","type":"journal-article","created":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T12:02:00Z","timestamp":1685102520000},"page":"9679-9689","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The influence of selected microRNAs on the expression profile of genes and proteins related to the tumor necrosis factor-alpha signaling pathways in endometrioid endometrial cancer"],"prefix":"10.1007","volume":"149","author":[{"given":"Nikola","family":"Zmarz\u0142y","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Szymon","family":"Januszyk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawe\u0142","family":"Mieszcza\u0144ski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Czarniecka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Bednarska-Czerwi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariusz","family":"Boro\u0144","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcin","family":"Oplawski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beniamin Oskar","family":"Grabarek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,26]]},"reference":[{"key":"4863_CR1","doi-asserted-by":"publisher","first-page":"bav006","DOI":"10.1093\/database\/bav006","volume":"2015","author":"F Belinky","year":"2015","unstructured":"Belinky F, Nativ N, Stelzer G et al (2015) PathCards: multi-source consolidation of human biological pathways. Database (oxford) 2015:bav006. https:\/\/doi.org\/10.1093\/database\/bav006","journal-title":"Database (oxford)"},{"key":"4863_CR2","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3390\/cells11111836","volume":"11","author":"J Bloomfield","year":"2022","unstructured":"Bloomfield J, Sabbah M, Castela M et al (2022) Clinical value and molecular function of circulating MicroRNAs in endometrial cancer regulation: a systematic review. Cells 11:1836. https:\/\/doi.org\/10.3390\/cells11111836","journal-title":"Cells"},{"key":"4863_CR3","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.3390\/jcm10132787","volume":"10","author":"D Boro\u0144","year":"2021","unstructured":"Boro\u0144 D, Nowakowski R, Grabarek BO et al (2021) Expression pattern of leptin and its receptors in endometrioid endometrial cancer. J Clin Med 10:2787. https:\/\/doi.org\/10.3390\/jcm10132787","journal-title":"J Clin Med"},{"key":"4863_CR4","doi-asserted-by":"publisher","first-page":"2333","DOI":"10.1074\/jbc.M109.090522","volume":"285","author":"P Broglie","year":"2010","unstructured":"Broglie P, Matsumoto K, Akira S et al (2010) Transforming growth factor beta-activated kinase 1 (TAK1) kinase adaptor, TAK1-binding protein 2, plays dual roles in TAK1 signaling by recruiting both an activator and an inhibitor of TAK1 kinase in tumor necrosis factor signaling pathway. J Biol Chem 285:2333\u20132339. https:\/\/doi.org\/10.1074\/jbc.M109.090522","journal-title":"J Biol Chem"},{"key":"4863_CR5","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.omtn.2020.04.002","volume":"20","author":"C Chakraborty","year":"2020","unstructured":"Chakraborty C, Sharma AR, Sharma G, Lee S-S (2020) The interplay among miRNAs, major cytokines, and cancer-related inflammation. Mol Ther Nucleic Acids 20:606\u2013620. https:\/\/doi.org\/10.1016\/j.omtn.2020.04.002","journal-title":"Mol Ther Nucleic Acids"},{"key":"4863_CR6","doi-asserted-by":"publisher","first-page":"e1034","DOI":"10.1038\/cddis.2013.553","volume":"5","author":"L Chen","year":"2014","unstructured":"Chen L, L\u00fc M-H, Zhang D et al (2014) miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase. Cell Death Dis 5:e1034. https:\/\/doi.org\/10.1038\/cddis.2013.553","journal-title":"Cell Death Dis"},{"key":"4863_CR7","doi-asserted-by":"publisher","first-page":"E133","DOI":"10.3390\/cells7090133","volume":"7","author":"J Concetti","year":"2018","unstructured":"Concetti J, Wilson CL (2018) NFKB1 and cancer: friend or foe? Cells 7:E133. https:\/\/doi.org\/10.3390\/cells7090133","journal-title":"Cells"},{"key":"4863_CR8","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3389\/fonc.2020.01772","volume":"10","author":"Y Dai","year":"2020","unstructured":"Dai Y, Chen Z, Zhao W et al (2020) miR-29a-5p regulates the proliferation, invasion, and migration of gliomas by targeting DHRS4. Front Oncol 10:1772. https:\/\/doi.org\/10.3389\/fonc.2020.01772","journal-title":"Front Oncol"},{"key":"4863_CR9","doi-asserted-by":"publisher","first-page":"32421","DOI":"10.18632\/oncotarget.8718","volume":"7","author":"W Dang","year":"2016","unstructured":"Dang W, Qin Z, Fan S et al (2016) miR-1207\u20135p suppresses lung cancer growth and metastasis by targeting CSF1. Oncotarget 7:32421\u201332432. https:\/\/doi.org\/10.18632\/oncotarget.8718","journal-title":"Oncotarget"},{"key":"4863_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.4103\/sjg.SJG_483_16","volume":"23","author":"NS Demirci","year":"2017","unstructured":"Demirci NS, Dogan M, Erdem GU et al (2017) Is plasma caveolin-1 level a prognostic biomarker in metastatic pancreatic cancer? Saudi J Gastroenterol 23:183\u2013189. https:\/\/doi.org\/10.4103\/sjg.SJG_483_16","journal-title":"Saudi J Gastroenterol"},{"key":"4863_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1186\/s12885-015-1477-5","volume":"15","author":"N Diaz-Valdivia","year":"2015","unstructured":"Diaz-Valdivia N, Bravo D, Huerta H et al (2015) Enhanced caveolin-1 expression increases migration, anchorage-independent growth and invasion of endometrial adenocarcinoma cells. BMC Cancer 15:463. https:\/\/doi.org\/10.1186\/s12885-015-1477-5","journal-title":"BMC Cancer"},{"key":"4863_CR12","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.febslet.2014.12.002","volume":"589","author":"Y Gao","year":"2015","unstructured":"Gao Y, Liu T, Huang Y (2015) MicroRNA-134 suppresses endometrial cancer stem cells by targeting POGLUT1 and Notch pathway proteins. FEBS Lett 589:207\u2013214. https:\/\/doi.org\/10.1016\/j.febslet.2014.12.002","journal-title":"FEBS Lett"},{"key":"4863_CR13","first-page":"5705","volume":"11","author":"Y Guan","year":"2018","unstructured":"Guan Y, Gong Z, Xiao T, Li Z (2018) Knockdown of miR-572 suppresses cell proliferation and promotes apoptosis in renal cell carcinoma cells by targeting the NF2\/Hippo signaling pathway. Int J Clin Exp Pathol 11:5705\u20135714","journal-title":"Int J Clin Exp Pathol"},{"key":"4863_CR14","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1159\/000479903","volume":"42","author":"M He","year":"2017","unstructured":"He M, Zhan M, Chen W et al (2017) MiR-143-5p deficiency triggers EMT and metastasis by targeting HIF-1\u03b1 in gallbladder cancer. Cell Physiol Biochem 42:2078\u20132092. https:\/\/doi.org\/10.1159\/000479903","journal-title":"Cell Physiol Biochem"},{"key":"4863_CR15","doi-asserted-by":"publisher","first-page":"e0213463","DOI":"10.1371\/journal.pone.0213463","volume":"14","author":"E-W Hsing","year":"2019","unstructured":"Hsing E-W, Shiah S-G, Peng H-Y et al (2019) TNF-\u03b1-induced miR-450a mediates TMEM182 expression to promote oral squamous cell carcinoma motility. PLoS\u00a0One 14:e0213463. https:\/\/doi.org\/10.1371\/journal.pone.0213463","journal-title":"PLoS\u00a0One"},{"key":"4863_CR16","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1016\/j.ajpath.2018.05.008","volume":"188","author":"I Koeck","year":"2018","unstructured":"Koeck I, Hashemi Gheinani A, Baumgartner U et al (2018) Tumor necrosis factor-\u03b1 initiates miRNA-mRNA signaling cascades in obstruction-induced bladder dysfunction. Am J Pathol 188:1847\u20131864. https:\/\/doi.org\/10.1016\/j.ajpath.2018.05.008","journal-title":"Am J Pathol"},{"key":"4863_CR17","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1038\/s41419-018-1091-y","volume":"9","author":"P Kong","year":"2018","unstructured":"Kong P, Chen L, Yu M et al (2018) miR-3178 inhibits cell proliferation and metastasis by targeting Notch1 in triple-negative breast cancer. Cell Death Dis 9:1059. https:\/\/doi.org\/10.1038\/s41419-018-1091-y","journal-title":"Cell Death Dis"},{"key":"4863_CR18","doi-asserted-by":"publisher","first-page":"3576","DOI":"10.1038\/onc.2016.509","volume":"36","author":"T-S Lau","year":"2017","unstructured":"Lau T-S, Chan LK-Y, Wong EC-H et al (2017) A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNF\u03b1-TGF\u03b1-EGFR. Oncogene 36:3576\u20133587. https:\/\/doi.org\/10.1038\/onc.2016.509","journal-title":"Oncogene"},{"key":"4863_CR19","doi-asserted-by":"publisher","first-page":"3261","DOI":"10.3892\/or.2018.6745","volume":"40","author":"Y Liang","year":"2018","unstructured":"Liang Y, Li E, Min J et al (2018) miR-29a suppresses the growth and metastasis of hepatocellular carcinoma through IFITM3. Oncol Rep 40:3261\u20133272. https:\/\/doi.org\/10.3892\/or.2018.6745","journal-title":"Oncol Rep"},{"key":"4863_CR20","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.21037\/tlcr-21-906","volume":"10","author":"Q Ma","year":"2021","unstructured":"Ma Q, Zhang J, Huang J et al (2021) Decreased miR-940 expression can predict a negative prognosis in early-stage nonsmoking female lung adenocarcinoma. Transl Lung Cancer Res 10:4293\u20134302. https:\/\/doi.org\/10.21037\/tlcr-21-906","journal-title":"Transl Lung Cancer Res"},{"key":"4863_CR21","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41419-018-1119-3","volume":"9","author":"L Meng","year":"2018","unstructured":"Meng L, Liu F, Ju Y et al (2018) Tumor suppressive miR-6775-3p inhibits ESCC progression through forming a positive feedback loop with p53 via MAGE-A family proteins. Cell Death Dis 9:1057. https:\/\/doi.org\/10.1038\/s41419-018-1119-3","journal-title":"Cell Death Dis"},{"key":"4863_CR22","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3389\/fonc.2020.00584","volume":"10","author":"MF Mercogliano","year":"2020","unstructured":"Mercogliano MF, Bruni S, Elizalde PV, Schillaci R (2020) Tumor necrosis factor \u03b1 blockade: an opportunity to tackle breast cancer. Front Oncol 10:584. https:\/\/doi.org\/10.3389\/fonc.2020.00584","journal-title":"Front Oncol"},{"key":"4863_CR23","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.1038\/onc.2013.356","volume":"33","author":"H Oshima","year":"2014","unstructured":"Oshima H, Ishikawa T, Yoshida GJ et al (2014) TNF-\u03b1\/TNFR1 signaling promotes gastric tumorigenesis through induction of Noxo1 and Gna14 in tumor cells. Oncogene 33:3820\u20133829. https:\/\/doi.org\/10.1038\/onc.2013.356","journal-title":"Oncogene"},{"key":"4863_CR24","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/path.1666","volume":"204","author":"J Pallares","year":"2004","unstructured":"Pallares J, Mart\u00ednez-Guitarte JL, Dolcet X et al (2004) Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma. J Pathol 204:569\u2013577. https:\/\/doi.org\/10.1002\/path.1666","journal-title":"J Pathol"},{"key":"4863_CR25","doi-asserted-by":"publisher","first-page":"3092","DOI":"10.3892\/or.2018.6649","volume":"40","author":"X Pan","year":"2018","unstructured":"Pan X, Li Z, Zhao L et al (2018) microRNA-572 functions as an oncogene and a potential biomarker for renal cell carcinoma prognosis. Oncol Rep 40:3092\u20133101. https:\/\/doi.org\/10.3892\/or.2018.6649","journal-title":"Oncol Rep"},{"key":"4863_CR26","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.2147\/OTT.S191317","volume":"12","author":"X-L Qian","year":"2019","unstructured":"Qian X-L, Pan Y-H, Huang Q-Y et al (2019) Caveolin-1: a multifaceted driver of breast cancer progression and its application in clinical treatment. Onco Targets Ther 12:1539\u20131552. https:\/\/doi.org\/10.2147\/OTT.S191317","journal-title":"Onco Targets Ther"},{"key":"4863_CR27","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.ygyno.2021.02.030","volume":"161","author":"A Raffone","year":"2021","unstructured":"Raffone A, Travaglino A, Raimondo D et al (2021) Tumor-infiltrating lymphocytes and POLE mutation in endometrial carcinoma. Gynecol Oncol 161:621\u2013628. https:\/\/doi.org\/10.1016\/j.ygyno.2021.02.030","journal-title":"Gynecol Oncol"},{"key":"4863_CR28","doi-asserted-by":"publisher","first-page":"628094","DOI":"10.3389\/fonc.2021.628094","volume":"11","author":"S Rajendiran","year":"2021","unstructured":"Rajendiran S, Maji S, Haddad A et al (2021) MicroRNA-940 as a potential serum biomarker for prostate cancer. Front Oncol 11:628094. https:\/\/doi.org\/10.3389\/fonc.2021.628094","journal-title":"Front Oncol"},{"key":"4863_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40644-018-0180-6","volume":"18","author":"S Rizzo","year":"2018","unstructured":"Rizzo S, Femia M, Buscarino V et al (2018) Endometrial cancer: an overview of novelties in treatment and related imaging keypoints for local staging. Cancer Imaging 18:45. https:\/\/doi.org\/10.1186\/s40644-018-0180-6","journal-title":"Cancer Imaging"},{"key":"4863_CR30","doi-asserted-by":"publisher","first-page":"3213","DOI":"10.1038\/s41419-017-0048-x","volume":"8","author":"Z Shen","year":"2017","unstructured":"Shen Z, Zhou R, Liu C et al (2017) MicroRNA-105 is involved in TNF-\u03b1-related tumor microenvironment enhanced colorectal cancer progression. Cell Death Dis 8:3213. https:\/\/doi.org\/10.1038\/s41419-017-0048-x","journal-title":"Cell Death Dis"},{"key":"4863_CR31","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2147\/OTT.S227644","volume":"13","author":"Y Shen","year":"2020","unstructured":"Shen Y, Chen G, Gao H et al (2020) miR-939-5p contributes to the migration and invasion of pancreatic cancer by targeting ARHGAP4. Onco Targets Ther 13:389\u2013399. https:\/\/doi.org\/10.2147\/OTT.S227644","journal-title":"Onco Targets Ther"},{"key":"4863_CR32","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.molonc.2012.07.002","volume":"7","author":"HO Smith","year":"2013","unstructured":"Smith HO, Stephens ND, Qualls CR et al (2013) The clinical significance of inflammatory cytokines in primary cell culture in endometrial carcinoma. Mol Oncol 7:41\u201354. https:\/\/doi.org\/10.1016\/j.molonc.2012.07.002","journal-title":"Mol Oncol"},{"key":"4863_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of Incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71:209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"4863_CR34","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s12032-011-9900-5","volume":"29","author":"Y Tang","year":"2012","unstructured":"Tang Y, Zeng X, He F et al (2012) Caveolin-1 is related to invasion, survival, and poor prognosis in hepatocellular cancer. Med Oncol 29:977\u2013984. https:\/\/doi.org\/10.1007\/s12032-011-9900-5","journal-title":"Med Oncol"},{"key":"4863_CR35","doi-asserted-by":"publisher","first-page":"D360","DOI":"10.1093\/nar\/gkx1144","volume":"46","author":"T Tokar","year":"2018","unstructured":"Tokar T, Pastrello C, Rossos AEM et al (2018) mirDIP 4.1-integrative database of human microRNA target predictions. Nucleic Acids Res 46:D360\u2013D370. https:\/\/doi.org\/10.1093\/nar\/gkx1144","journal-title":"Nucleic Acids Res"},{"key":"4863_CR36","doi-asserted-by":"publisher","first-page":"14134","DOI":"10.1038\/s41598-021-93681-z","volume":"11","author":"Y Tokumaru","year":"2021","unstructured":"Tokumaru Y, Oshi M, Huyser MR et al (2021) Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer. Sci Rep 11:14134. https:\/\/doi.org\/10.1038\/s41598-021-93681-z","journal-title":"Sci Rep"},{"key":"4863_CR37","doi-asserted-by":"publisher","first-page":"2625","DOI":"10.1007\/s00268-017-4065-9","volume":"41","author":"B Torrej\u00f3n","year":"2017","unstructured":"Torrej\u00f3n B, Crist\u00f3bal I, Rojo F, Garc\u00eda-Foncillas J (2017) Caveolin-1 is markedly downregulated in patients with early-stage colorectal cancer. World J Surg 41:2625\u20132630. https:\/\/doi.org\/10.1007\/s00268-017-4065-9","journal-title":"World J Surg"},{"key":"4863_CR38","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1016\/j.bbamcr.2015.05.033","volume":"1853","author":"S Tr\u00e9houx","year":"2015","unstructured":"Tr\u00e9houx S, Lahdaoui F, Delpu Y et al (2015) Micro-RNAs miR-29a and miR-330-5p function as tumor suppressors by targeting the MUC1 mucin in pancreatic cancer cells. Biochim Biophys Acta 1853:2392\u20132403. https:\/\/doi.org\/10.1016\/j.bbamcr.2015.05.033","journal-title":"Biochim Biophys Acta"},{"key":"4863_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/400_2008_26","volume":"49","author":"H Wajant","year":"2009","unstructured":"Wajant H (2009) The role of TNF in cancer. Results Probl Cell Differ 49:1\u201315. https:\/\/doi.org\/10.1007\/400_2008_26","journal-title":"Results Probl Cell Differ"},{"key":"4863_CR40","doi-asserted-by":"publisher","first-page":"3475","DOI":"10.2147\/OTT.S158764","volume":"11","author":"N Wang","year":"2018","unstructured":"Wang N, He X, Zhou R et al (2018) STAT3 induces colorectal carcinoma progression through a novel miR-572-MOAP-1 pathway. Onco Targets Ther 11:3475\u20133484. https:\/\/doi.org\/10.2147\/OTT.S158764","journal-title":"Onco Targets Ther"},{"key":"4863_CR41","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.canlet.2020.05.038","volume":"489","author":"B Wang","year":"2020","unstructured":"Wang B, Mao J-H, Wang B-Y et al (2020) Exosomal miR-1910-3p promotes proliferation, metastasis, and autophagy of breast cancer cells by targeting MTMR3 and activating the NF-\u03baB signaling pathway. Cancer Lett 489:87\u201399. https:\/\/doi.org\/10.1016\/j.canlet.2020.05.038","journal-title":"Cancer Lett"},{"key":"4863_CR42","doi-asserted-by":"publisher","first-page":"C494","DOI":"10.1152\/ajpcell.00458.2004","volume":"288","author":"TM Williams","year":"2005","unstructured":"Williams TM, Lisanti MP (2005) Caveolin-1 in oncogenic transformation, cancer, and metastasis. Am J Physiol Cell Physiol 288:C494-506. https:\/\/doi.org\/10.1152\/ajpcell.00458.2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"4863_CR43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.omto.2021.08.001","volume":"22","author":"Y Wu","year":"2021","unstructured":"Wu Y, Dai F, Zhang Y et al (2021) miR-1207-5p suppresses laryngeal squamous cell carcinoma progression by downregulating SKA3 and inhibiting epithelial-mesenchymal transition. Mol Ther Oncolytics 22:152\u2013165. https:\/\/doi.org\/10.1016\/j.omto.2021.08.001","journal-title":"Mol Ther Oncolytics"},{"key":"4863_CR44","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11845-021-02527-0","volume":"191","author":"J-C Wu","year":"2022","unstructured":"Wu J-C, Liu Z-H, Ding X, Ke R-S (2022) miR-3178 as a prognostic indicator and tumor suppressor of gastric cancer. Ir J Med Sci 191:139\u2013145. https:\/\/doi.org\/10.1007\/s11845-021-02527-0","journal-title":"Ir J Med Sci"},{"key":"4863_CR45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbrc.2021.08.037","volume":"575","author":"H Xu","year":"2021","unstructured":"Xu H, He Y, Lin L et al (2021a) MiR-1207-5p targets PYCR1 to inhibit the progression of prostate cancer. Biochem Biophys Res Commun 575:56\u201364. https:\/\/doi.org\/10.1016\/j.bbrc.2021.08.037","journal-title":"Biochem Biophys Res Commun"},{"key":"4863_CR46","doi-asserted-by":"publisher","first-page":"228","DOI":"10.18632\/aging.103669","volume":"13","author":"W Xu","year":"2021","unstructured":"Xu W, Song C, Wang X et al (2021b) Downregulation of miR-155-5p enhances the anti-tumor effect of cetuximab on triple-negative breast cancer cells via inducing cell apoptosis and pyroptosis. Aging (albany NY) 13:228\u2013240. https:\/\/doi.org\/10.18632\/aging.103669","journal-title":"Aging (albany NY)"},{"key":"4863_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3892\/ol.2022.13268","volume":"23","author":"J Xu","year":"2022","unstructured":"Xu J, Li X, Zhang P et al (2022) miR-143-5p suppresses breast cancer progression by targeting the HIF-1\u03b1-related GLUT1 pathway. Oncol Lett 23:147. https:\/\/doi.org\/10.3892\/ol.2022.13268","journal-title":"Oncol Lett"},{"key":"4863_CR48","doi-asserted-by":"publisher","first-page":"9601876","DOI":"10.1155\/2020\/9601876","volume":"2020","author":"W-X Xue","year":"2020","unstructured":"Xue W-X, Zhang M-Y, Linull R et al (2020) Serum miR-1228-3p and miR-181a-5p as Noninvasive biomarkers for non-small cell lung cancer diagnosis and prognosis. Biomed Res Int 2020:9601876. https:\/\/doi.org\/10.1155\/2020\/9601876","journal-title":"Biomed Res Int"},{"key":"4863_CR49","doi-asserted-by":"publisher","first-page":"332","DOI":"10.12659\/msm.907782","volume":"24","author":"J Yang","year":"2018","unstructured":"Yang J, Zhu T, Zhao R et al (2018) Caveolin-1 inhibits proliferation, migration, and invasion of human colorectal cancer cells by suppressing phosphorylation of epidermal growth factor receptor. Med Sci Monit 24:332\u2013341. https:\/\/doi.org\/10.12659\/msm.907782","journal-title":"Med Sci Monit"},{"key":"4863_CR50","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/acel.12606","volume":"16","author":"D-M Yu","year":"2017","unstructured":"Yu D-M, Jung SH, An H-T et al (2017) Caveolin-1 deficiency induces premature senescence with mitochondrial dysfunction. Aging Cell 16:773\u2013784. https:\/\/doi.org\/10.1111\/acel.12606","journal-title":"Aging Cell"},{"key":"4863_CR51","doi-asserted-by":"publisher","first-page":"831","DOI":"10.3389\/fonc.2019.00831","volume":"9","author":"S Yu","year":"2019","unstructured":"Yu S, Shao H, Ban X et al (2019) Detection of POLE subtypes in high-grade endometrioid carcinoma by BaseScope-ISH assay. Front Oncol 9:831. https:\/\/doi.org\/10.3389\/fonc.2019.00831","journal-title":"Front Oncol"},{"key":"4863_CR52","doi-asserted-by":"publisher","first-page":"3709","DOI":"10.26355\/eurrev_201905_17794","volume":"23","author":"C Zhang","year":"2019","unstructured":"Zhang C, Lv G-Q, Cui L-F et al (2019) MicroRNA-572 targets CDH1 to promote metastasis of Wilms\u2019 tumor. Eur Rev Med Pharmacol Sci 23:3709\u20133717. https:\/\/doi.org\/10.26355\/eurrev_201905_17794","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4863_CR53","doi-asserted-by":"publisher","first-page":"3820","DOI":"10.3892\/ol.2018.7735","volume":"15","author":"P Zhao","year":"2018","unstructured":"Zhao P, Zhang Z (2018) TNF-\u03b1 promotes colon cancer cell migration and invasion by upregulating TROP-2. Oncol Lett 15:3820\u20133827. https:\/\/doi.org\/10.3892\/ol.2018.7735","journal-title":"Oncol Lett"},{"key":"4863_CR54","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.3892\/ijmm.2019.4333","volume":"44","author":"X Zhao","year":"2019","unstructured":"Zhao X, Li J, Yu D (2019) MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K\/Akt pathway. Int J Mol Med 44:1833\u20131843. https:\/\/doi.org\/10.3892\/ijmm.2019.4333","journal-title":"Int J Mol Med"},{"key":"4863_CR55","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41419-021-03773-x","volume":"12","author":"J Zhao","year":"2021","unstructured":"Zhao J, Wang X, Mi Z et al (2021a) STAT3\/miR-135b\/NF-\u03baB axis confers aggressiveness and unfavorable prognosis in non-small-cell lung cancer. Cell Death Dis 12:493. https:\/\/doi.org\/10.1038\/s41419-021-03773-x","journal-title":"Cell Death Dis"},{"key":"4863_CR56","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3892\/or.2020.7844","volume":"45","author":"M Zhao","year":"2021","unstructured":"Zhao M, Ji H, Fu Q et al (2021b) MicroRNA-134-3p inhibits ovarian cancer progression by targeting flap structure-specific endonuclease 1 in vitro. Oncol Rep 45:119\u2013128. https:\/\/doi.org\/10.3892\/or.2020.7844","journal-title":"Oncol Rep"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04863-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-04863-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04863-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T13:06:22Z","timestamp":1691845582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-04863-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,26]]},"references-count":56,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4863"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-04863-3","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,26]]},"assertion":[{"value":"21 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Bioethical Committee operating at the Regional Medical Chamber in Krakow (185\/KBL\/OIL\/2020 and 186\/KBL\/OIL\/2020, 20 September 2020).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all participants involved in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent has been obtained from the patients to publish this paper.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}